US2005096736A1PendingUtilityA1

Percutaneous heart valve devices

Priority: Jan 31, 2000Filed: Apr 30, 2004Published: May 5, 2005
Est. expiryJan 31, 2020(expired)· nominal 20-yr term from priority
A61F 2220/0016A61F 2/2475A61F 2220/005A61F 2220/0075A61F 2/2418
40
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention includes a medical device and more specifically relates to a valve found generally within a frame. In a preferred device, the frame preferably comprises a self-expanding stent frame, and the valve has at least one expandable and contractible pocket member within the stent frame for resisting and permitting fluid flow, respectively.

Claims

exact text as granted — not AI-modified
1 - 36 . (canceled)  
   
   
       37 . A percutaneous heart valve device, comprising: 
 a frame having a first configuration suitable for percutaneous vascular delivery to a vascular site for providing a heart valve, and a second, expanded configuration adapted for deployment at the vascular site;    said expanded configuration being generally cylindrical in shape and providing an inner lumen, said expanded configuration further providing a first frame end and a second frame end;    said expanded configuration of said frame providing a plurality of struts that reverse direction and thereby provide a plurality of bends with apexes occurring at said second frame end;    said first frame end providing an inlet end of the valve device, and said second frame end providing an outlet end of the valve device;    a flexible collagenous biomaterial;    said flexible collagenous biomaterial forming at least two flexible valve leaflets within said inner lumen;    said at least two flexible valve leaflets each extending substantially from said first frame end to said second frame end; and    said at least two flexible valve leaflets forming a valve orifice at the outlet end of said frame.    
   
   
       38 . The percutaneous heart valve device of  claim 37 , wherein said flexible collagenous material is attached to said frame at least at said outlet end.  
   
   
       39 . The percutaneous heart valve device of  claim 37 , wherein: 
 said apexes of said bends are substantially co-terminal.    
   
   
       40 . A percutaneous heart valve device, comprising: 
 a frame having a first configuration suitable for percutaneous vascular delivery to a vascular site for providing a heart valve, and a second, expanded configuration adapted for deployment at the vascular site;    said expanded configuration being generally cylindrical in shape and providing an inner lumen, said expanded configuration further providing a first frame end and a second frame end;    said first frame end providing an inlet end of the valve device, and said second frame end providing an outlet end of the valve device;    a flexible collagenous biomaterial;    said flexible collagenous biomaterial forming at least two flexible valve leaflets within said inner lumen;    said at least two flexible valve leaflets each extending substantially from said first frame end to said second frame end;    said at least two flexible valve leaflets forming a valve orifice at the outlet end of said frame; and    said flexible collagenous material attached to said frame at least at said outlet end.    
   
   
       41 . The percutaneous heart valve device of  claim 40 , wherein: 
 said expanded configuration of said frame provides a plurality of struts that reverse direction and thereby provide a plurality of bends.    
   
   
       42 . The percutaneous heart valve device of  claim 40 , wherein said frame is a self-expanding frame.  
   
   
       43 . A percutaneous heart valve device, comprising: 
 a frame having a first configuration suitable for percutaneous vascular delivery to a vascular site for providing a heart valve, and a second, expanded configuration adapted for deployment at the vascular site;    said expanded configuration being generally cylindrical in shape and providing an inner lumen, said expanded configuration further providing a first frame end and a second frame end;    said expanded configuration of said frame providing a plurality of struts that reverse direction and thereby provide a plurality of bends with apexes occurring at said second frame end;    said first frame end providing an inlet end of the valve device, and said second frame end providing an outlet end of the valve device;    a flexible material;    said flexible material forming at least two flexible valve leaflets within said inner lumen;    said at least two flexible valve leaflets each extending substantially from said first frame end to said second frame end;    said at least two flexible valve leaflets forming a valve orifice at the outlet end of said frame; and    said flexible material attached to said frame at least at said outlet end.    
   
   
       44 . The percutaneous heart valve device of  claim 43 , wherein: 
 said flexible material is a collagenous biomaterial.    
   
   
       45 . A percutaneous heart valve device, comprising: 
 a frame having a first configuration suitable for percutaneous vascular delivery to a vascular site for providing a heart valve, and a second, expanded configuration adapted for deployment at the vascular site;    said expanded configuration providing a first frame end and a second frame end;    said expanded configuration of said frame providing a plurality of struts that reverse direction and thereby provide a plurality of bends with apexes occurring at said second frame end and wherein each of said apexes is substantially co-terminal with the other apexes;    said flexible collagenous biomaterial formed to provide at least two flexible valve leaflets;    said at least two flexible valve leaflets having cooperating leaflet edge portions, said cooperating leaflet edge portions having outer ends connected to said frame and extending inwardly therefrom to form a valve orifice at said second end of said frame.    
   
   
       46 . The percutaneous heart valve device of  claim 45 , wherein: 
 said outer ends of said leaflet edge portions are connected to said frame by sutures.    
   
   
       47 . The percutaneous heart valve device of  claim 45 , wherein: 
 said frame is a self-expanding frame.    
   
   
       48 . A percutaneous heart valve device, comprising: 
 a frame having a first configuration suitable for percutaneous vascular delivery to a vascular site for providing a heart valve, and a second, expanded configuration for deployment at the vascular site;    said expanded configuration being generally cylindrical in shape and providing an inner lumen, said expanded configuration further providing a first frame end and a second frame end;    said first frame end providing an inlet end of the valve device, and said second frame end providing an outlet end of the valve device;    a flexible collagenous biomaterial;    said flexible collagenous biomaterial extending substantially from said first frame end to said second frame end;    said flexible collagenous biomaterial forming at least two flexible valve leaflets defining a valve orifice at the outlet end of said frame; and    said flexible collagenous material attached to said frame at least at said outlet end.    
   
   
       49 . The percutaneous heart valve device of  claim 48 , wherein: 
 said frame is a self-expanding frame.    
   
   
       50 . A percutaneous heart valve device, comprising: 
 a frame having a first configuration suitable for percutaneous vascular delivery to a vascular site for providing a heart valve, and a second configuration for deployment at the vascular site, said second configuration expanded relative to said first configuration;    said second, expanded configuration providing a first frame end and a second frame end;    a flexible collagenous biomaterial attached to said frame;    said flexible collagenous biomaterial formed to provide at least two flexible valve leaflets;    said at least two flexible valve leaflets forming a valve orifice at said second frame end;    said at least two flexible leaflets extending only partially between said second frame end and said first frame end;    said at least two flexible valve leaflets having cooperating leaflet edge portions, said cooperating leaflet edge portions forming a valve orifice at said second end of said frame.    
   
   
       51 . The percutaneous heart valve device of  claim 50 , wherein: 
 said cooperating leaflet edge portions have ends connected at said second frame end.    
   
   
       52 . The percutaneous heart valve device of  claim 50 , wherein: 
 said frame is a self-expanding frame.    
   
   
       53 . A percutaneous heart valve device, comprising: 
 a frame having a first configuration suitable for percutaneous vascular delivery to a vascular site for providing a heart valve, and a second configuration suitable for deployment at the vascular site, said second configuration expanded relative to said first configuration;    said second configuration providing a first frame end and a second frame end;    a flexible collagenous biomaterial;    said flexible collagenous biomaterial formed to provide at least two flexible valve leaflets;    said at least two flexible leaflets extending only partially between said second frame end and said first frame end;    said at least two flexible leaflets having portions attached to said frame between said first frame end and said second frame end; and    said at least two flexible valve leaflets having orifice-forming leaflet edge portions, said orifice-forming leaflet edge portions cooperating to form a valve orifice at said second end of said frame.    
   
   
       54 . The percutaneous heart valve device of  claim 53 , wherein: 
 said orifice-forming leaflet edge portions have ends attached to said frame.    
   
   
       55 . The percutaneous heart valve device of  claim 53 , wherein: 
 said frame is a self-expanding frame.

Join the waitlist — get patent alerts

Track US2005096736A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.